SEARCH

SEARCH BY CITATION

REFERENCES

  • Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ. 2008. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172:250254.
  • Alessi A, Bragg AD, Percival JM, Yoo J, Albrecht DE, Froehner SC, Adams ME. 2006. gamma-Syntrophin scaffolding is spatially and functionally distinct from that of the alpha/beta syntrophins. Exp Cell Res 312:30843095.
  • Anderson JE. 2000. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell 11:18591874.
  • Anderson JE, Carvalho RS, Yen E, Scott JE. 1993. Measurement of strain in cultured bone and fetal muscle and lung cells. In Vitro Cell Dev Biol 29A:183186.
  • Anderson JE, Garrett K, Moor A, McIntosh L, Penner K. 1998. Dystrophy and myogenesis in mdx diaphragm muscle. Muscle Nerve 21:11531165.
  • Anderson JE, Vargas C. 2003. Correlated NOS-Iμ; and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment. Neuromuscul Disord 13:388396.
  • Archer JD, Vargas CC, Anderson JE. 2006. Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort. FASEB J 20:738740.
  • Blake DJ, Weir A, Newey SE, Davies KE. 2002. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82:291329.
  • Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. 1995. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743752.
  • Brunelli S, Sciorati C, D'Antona G, Innocenzi A, Covarello D, Galvez BG, Perrotta C, Monopoli A, Sanvito F, Bottinelli R, Ongini E, Cossu G, Clementi E. 2007. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci USA 104:264269.
  • Campbell KP, Stull JT. 2003. Skeletal muscle basement membrane-sarcolemma-cytoskeleton interaction minireview series. J Biol Chem 278:1259912600.
  • Clarac F, Brocard F, Vinay L. 2004. The maturation of locomotor networks. Prog Brain Res 143:5766.
  • Cotton S, Voudouris NJ, Greenwood KM. 2001. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol 43:497501.
  • Culligan K, Glover L, Dowling P, Ohlendieck K. 2001. Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. BMC Cell Biol 2:2.
  • Cyrulnik SE, Hinton VJ. 2008. Duchenne muscular dystrophy: a cerebellar disorder? Neurosci Biobehav Rev 32:486496.
  • Cyrulnik SE, Fee RJ, De V, Goldstein E, Hinton VJ. 2007. Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr 150:474478.
  • De Palma C, Clementi E. 2012. Nitric oxide in myogenesis and therapeutic muscle repair. Mol Neurobiol 46:682692.
  • den Dunnen JT, Casula L, Makover A, Bakker B, Yaffe D, Nudel U, van Ommen GJ. 1991. Mapping of dystrophin brain promoter: a deletion of this region is compatible with normal intellect. Neuromuscul Disord 1:327331.
  • Deng B, Glanzman D, Tidball JG. 2009. Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy. J Physiol 587:17691778.
  • Dittmer A, Dittmer J. 2006. Beta-actin is not a reliable loading control in Western blot analysis. Electrophoresis 27:28442845.
  • Dowling P, Lohan J, Ohlendieck K. 2003. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur J Cell Biol 82:222230.
  • Dubowitz V. 1965. Intellectual impairment in muscular dystrophy. Arch Dis Child 40:296301.
  • Engel AG, Yamamoto M, Fischbeck KH. 1994. Dystrophinopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology: basic and clinical. New York: McGraw-Hill, Inc. p 11301187.
  • Ervasti JM. 2007. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 1772:108117.
  • Felisari G, Martinelli BF, Bardoni A, Sironi M, Comi GP, Robotti M, Turconi AC, Lai M, Corrao G, Bresolin N. 2000. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 55:559564.
  • Ferreira A, Paganoni S. 2002. The formation of synapses in the central nervous system. Mol Neurobiol 26:6979.
  • Finn DM, Ohlendieck K. 1997. Rabbit brain and muscle isoforms containing the carboxy-terminal domain of 427 kDa skeletal muscle dystrophin exhibit similar biochemical properties. Neurosci Lett 222:2528.
  • Finn DM, Culligan KG, Ohlendieck K. 1998. Decreased expression of brain beta-dystroglycan in Duchenne muscular dystrophy but not in the mdx animal model. Biochem Biophys Res Commun 249:231235.
  • Garthwaite J. 2008. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:27832802.
  • Grozdanovic Z, Baumgarten HG. 1999. Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex. Histol Histopathol 14:243256.
  • Grozdanovic Z, Christova T, Gosztonyi G, Mellerowicz H, Blottner D, Gossrau R. 1997. Absence of nitric oxide synthase I despite the presence of the dystrophin complex in human striated muscle. Histochem J 29:97104.
  • Haenggi T, Fritschy JM. 2006. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 63:16141631.
  • Hamer PW, McGeachie JM, Davies MJ, Grounds MD. 2002. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 200:6979.
  • Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltran-Valero de BD, Gundesli H, Willer T, Satz JS, Crawford RW, Burden SJ, Kunz S, Oldstone MB, Accardi A, Talim B, Muntoni F, Topaloglu H, Dincer P, Campbell KP. 2011. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 364:939946.
  • Henion TR, Qu Q, Smith FI. 2003. Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development. Brain Res Mol Brain Res 112:177181.
  • Hinton VJ, De V, Nereo NE, Goldstein E, Stern Y. 2000. Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology 54:21272132.
  • Hinton VJ, Cyrulnik SE, Fee RJ, Batchelder A, Kiefel JM, Goldstein EM, Kaufmann P, De V. 2009. Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol 41:339346.
  • Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696702.
  • IHCWorld Protocols.Immunohistochemistry Protocol for Mouse Antibody on Mouse Tissues. 2008. http://www.ihcworld.com/_protocols/general_IHC/immuno_mom.htm.
  • Kanagawa M, Michele DE, Satz JS, Barresi R, Kusano H, Sasaki T, Timpl R, Henry MD, Campbell KP. 2005. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. FEBS Lett 579:47924796.
  • Lapidos KA, Kakkar R, McNally EM. 2004. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94:10231031.
  • Laskowski MB, Sanes JR. 1987. Topographic mapping of motor pools onto skeletal muscles. J Neurosci 7:252260.
  • Leiter JR, Anderson JE. 2010. Satellite cells are increasingly refractory to activation by nitric oxide and stretch in aged mouse-muscle cultures. Int J Biochem Cell Biol 42:132136.
  • Leiter JR, Upadhaya R, Anderson JE. 2012a. Nitric oxide and voluntary exercise together promote quadriceps hypertrophy and increase vascular density in female 18-mo-old mice. Am J Physiol Cell Physiol 302:C1306C1315.
  • Leiter JR, Upadhaya R, Anderson JE. 2012b. Nitric oxide and voluntary exercise together promote quadriceps hypertrophy and increase vascular density in female 18-month-old mice. Am J Physiol Cell Physiol 302:C1306C1315.
  • Leonelli M, Torrao AS, Britto LR. 2009. Unconventional neurotransmitters, neurodegeneration and neuroprotection. Braz J Med Biol Res 42:6875.
  • Lewis C, Ohlendieck K. 2010. Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem Biophys Res Commun 396:10241029.
  • Lewis C, Carberry S, Ohlendieck K. 2009. Proteomic profiling of x-linked muscular dystrophy. J Muscle Res Cell Motil 30:267269.
  • Li D, Bareja A, Judge L, Yue Y, Lai Y, Fairclough R, Davies KE, Chamberlain JS, Duan D. 2010. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci 123:20082013.
  • Lidov HG, Byers TJ, Watkins SC, Kunkel LM. 1990. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348:725728.
  • Merrick D, Stadler LK, Larner D, Smith J. 2009. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis Model Mech 2:374388.
  • Michele DE, Campbell KP. 2003. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 278:1545715460.
  • Mizunoya W, Upadhaya R, Burczynski FJ, Wang G, Anderson JE. 2011. Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm. Am J Physiol Cell Physiol 300:C1065C1077.
  • Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C. 1998. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet 80:3241.
  • Moizard MP, Toutain A, Fournier D, Berret F, Raynaud M, Billard C, Andres C, Moraine C. 2000. Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet 8:552556.
  • Moukhles H, Carbonetto S. 2001. Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain. J Neurochem 78:824834.
  • Muntoni F, Mateddu A, Serra G. 1991. Passive avoidance behaviour deficit in the mdx mouse. Neuromuscul Disord 1:121123.
  • Ogasawara H, Doi T, Kawato M. 2008. Systems biology perspectives on cerebellar long-term depression. Neurosignals 16:300317.
  • Pastoret C, Sebille A. 1995. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve 18:11471154.
  • Percival JM, Anderson KN, Gregorevic P, Chamberlain JS, Froehner SC. 2008. Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One 3:e3387.
  • Percival JM, Whitehead NP, Adams ME, Adamo CM, Beavo JA, Froehner SC. 2012. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol 228:7787.
  • Perronnet C, Vaillend C. 2010. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol 2010:849426.
  • Pierucci M, Galati S, Valentino M, Di M, V, Benigno A, Pitruzzella A, Muscat R, Di GG. 2011. Nitric oxide modulation of the Basal Ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. CNS Neurol Disord Drug Targets 10:777791.
  • Pilgram GS, Potikanond S, Baines RA, Fradkin LG, Noordermeer JN. 2010. The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol 41:121.
  • Pisconti A, Brunelli S, Di Padova M, De Palma C, Deponti D, Baesso S, Sartorelli V, Cossu G, Clementi E. 2006. Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J Cell Biol 172:233244.
  • Punkt K, Schering S, Loffler S, Minin EA, Samoilova VE, Hasselblatt M, Paulus W, Muller-Werdan U, Demus U, Koehler G, Boecker W, Buchwalow IB. 2006. Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophy. Biochem Biophys Res Commun 348:259264.
  • Punkt K, Schering S, Fritzsche M, Asmussen G, Minin EA, Samoilova VE, Muller FU, Schmitz W, Hasselblatt M, Paulus W, Muller-Werdan U, Slezak J, Koehler G, Boecker W, Buchwalow IB. 2007. Fibre-related nitric oxide synthase (NOS) in Duchenne muscular dystrophy. Acta Histochem 109:228236.
  • Ramaswamy KS, Palmer ML, van der Meulen JH, Renoux A, Kostrominova TY, Michele DE, Faulkner JA. 2011. Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J Physiol 589:11951208.
  • Rapaport D, Passos-Bueno MR, Takata RI, Campiotto S, Eggers S, Vainzof M, Makover A, Nudel U, Yaffe D, Zatz M. 1992. A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation. Neuromuscul Disord 2:117120.
  • Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, Campbell KP. 1993. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 268:1149611499.
  • Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez MD, Zarzuelo A, Martinez-Augustin O, de Medina FS. 2010. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401:318320.
  • Saito F, Blank M, Schroder J, Manya H, Shimizu T, Campbell KP, Endo T, Mizutani M, Kroger S, Matsumura K. 2005. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy. FEBS Lett 579:23592363.
  • Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, Pellegrino MA, Barresi R, Bresolin N, De Angelis MG, Campbell KP, Bottinelli R, Cossu G. 2003. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301:487492.
  • Satz JS, Ostendorf AP, Hou S, Turner A, Kusano H, Lee JC, Turk R, Nguyen H, Ross-Barta SE, Westra S, Hoshi T, Moore SA, Campbell KP. 2010. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci 30:1456014572.
  • Sciorati C, Miglietta D, Buono R, Pisa V, Cattaneo D, Azzoni E, Brunelli S, Clementi E. 2011. A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy. Pharmacol Res 64:210217.
  • Scott JE, Oulton MR, Anderson JE. 1994. Strain induces change in phospholipid and DNA synthesis, cAMP levels and cytoskeletal fibers in isolated fetal rabbit type II alveolar cells. Prog Respir Res 27:173178.
  • Segalat L, Grisoni K, Archer J, Vargas C, Bertrand A, Anderson JE. 2005. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy. Exp Cell Res 302:170179.
  • Sillitoe RV, Benson MA, Blake DJ, Hawkes R. 2003. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. J Neurosci 23:65766585.
  • Snow WM, Anderson JE, Jakobson LS. 2013a. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: A review. Neurosci Biobehav Rev 37:743752.
  • Snow WM, Fry M, Anderson JE. 2013b. Increased density of dystrophin protein in the lateral versus the vermal mouse cerebellum. Cell Mol Neurobiol 33:513520.
  • Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352:536539.
  • Straub V, Rafael JA, Chamberlain JS, Campbell KP. 1997. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139:375385.
  • Sugita S, Saito F, Tang J, Satz J, Campbell K, Sudhof TC. 2001. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol 154:435445.
  • Tatsumi R. 2010. Mechano-biology of skeletal muscle hypertrophy and regeneration: possible mechanism of stretch-induced activation of resident myogenic stem cells. Anim Sci J 81:1120.
  • Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, Johnston HM, Buckley MF. 2010. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One 5:e8803.
  • Tian M, Jacobson C, Gee SH, Campbell KP, Carbonetto S, Jucker M. 1996. Dystroglycan in the cerebellum is a laminin alpha 2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci 8:27392747.
  • Vaillend C, Billard JM, Laroche S. 2004. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Neurobiol Dis 17:1020.
  • Vinay L, Brocard F, Clarac F. 2000. Differential maturation of motoneurons innervating ankle flexor and extensor muscles in the neonatal rat. Eur J Neurosci 12:45624566.
  • Waite A, Brown SC, Blake DJ. 2012. The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci 35:487496.
  • Wang G, Burczynski FJ, Hasinoff BB, Zhang K, Lu Q, Anderson JE. 2009. Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis. Mol Pharm 6:895904.
  • Wehling M, Spencer MJ, Tidball JG. 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155:123131.
  • Wells KE, Torelli S, Lu Q, Brown SC, Partridge T, Muntoni F, Wells DJ. 2003. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul Disord 13:2131.
  • Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B, Gallati S, Steinlin M. 2011. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci 18:9095.
  • Wozniak AC, Anderson JE. 2007. Nitric oxide-dependence of satellite stem cell activation and quiescence on normal skeletal muscle fibers. Dev Dyn 236:240250.
  • Wozniak AC, Anderson JE. 2009. The dynamics of the nitric oxide release-transient from stretched muscle cells. Int J Biochem Cell Biol 41:625631.
  • Wozniak AC, Pilipowicz O, Yablonka-Reuveni Z, Greenway S, Craven S, Scott E, Anderson JE. 2003. C-met expression and mechanical activation of satellite cells on cultured muscle fibers. J Histochem Cytochem 51:14371445.